美诺华10.01%涨停，总市值63.05亿元

Core Viewpoint - Meinuo Pharma's stock experienced a significant increase of 10.01%, reaching a price of 28.68 yuan per share, with a trading volume of 1.4 billion yuan and a turnover rate of 23.46%, resulting in a total market capitalization of 6.305 billion yuan [1] Group 1: Company Overview - Meinuo Pharma is located in Ningbo High-tech Zone and specializes in the research, production, and sales of specialty APIs (including intermediates) and finished drugs [1] - The company is one of the leading exporters of specialty APIs to Europe, with products covering cardiovascular, central nervous system, and gastrointestinal therapeutic areas [1] - Since its listing, the company has adhered to a growth strategy of "internal growth + external expansion," focusing on continuous R&D innovation and business development [1] Group 2: Financial Performance - As of March 31, Meinuo Pharma had 27,600 shareholders, with an average of 7,720 circulating shares per person [2] - For the first quarter of 2025, the company achieved operating revenue of 276 million yuan, representing a year-on-year growth of 5.22% [2] - The net profit attributable to shareholders for the same period was 21.22 million yuan, showing a significant year-on-year increase of 51.12% [2]